Manage Your Liver
Q:

Diabetes on the rise!

Diabetes on the rise!
A:

A report published by the WHO (World Health Organisation)stated that the number of people living with diabetes almost quadrupled since 1980, from 108 million adults in 1980 to 422 million in 2014.Most of these people live in developing countries. The main causes of diabetes are overweight and obesity. [1]

 

Many people think that diabetes only affects the sugar level in the blood, thus affecting kidney health. But in fact, diabetes can cause a number of health issues, including affecting liver function which could lead to serious liver diseases. The is because diabetes raises the risk of having nonalcoholic fatty liver disease; this condition occurs in at least half the patients with type 2 diabetes and close to half of those with type 1 diabetes. Apart from diabetes, other conditions, such as obesity, high cholesterol level and high blood pressure, also increase the risk of nonalcoholic fatty liver disease.

 

According to various data, diabetes is now the most common cause of liver disease in the U.S.Diabetes together with nonalcoholic fatty liver disease (NAFLD) are now recognized as the most common causes of cirrhosis, which has become the third leading reason for liver transplant in the U.S. [3][4] Moreover, most diabetes patients often have other chronic health problems which require long term medications. Long term use of these medications may further damage liver function and health as all drugs and medications have various degrees of side effects. [5] 

 

Hence we can see that diabetes is actually closely related to liver health. But as there is no medication for nonalcoholic fatty liver disease (NAFLD), both doctors and diabetes patients often neglect the need for liver protection, resulting in the reduction of liver function, or even the development of liver diseases. In fact, diabetes can be controlled by diet, exercises, and using the correct medications. The use of effective measures to protect the liver function of diabetes patients should definitely not be overlooked!

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
A:
Chronic hepatitis C is a slow and progressive disease that causes liver inflammation, fibrosis and cirrhosis. Over a long period of time, hepatitis virus can cause long term damage that is often thought to be irreversible. But recent research is suggesting otherwise, that fibrotic or cirrhotic liver is reversible, allowing patients to regain liver function and improve health. The danger of cirrhosis Cirrhosis is end stage liver fibrosis, it is a
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us